Curis Inc (CRIS) stock
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3092% below fair value
$0.54+0.11 (+24.32%)
Close on Nov 17, 2026Market cap $1.13MP/E –Yield –
Curis operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Curis's operating cash flow for the twelve months ending Jun 30, 2026 was -$30.59M. For fiscal 2025 it was -$27.20M. The highest annual figure on record is -$1.63M in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$27.20M | – |
| FY2024 | Dec 31, 2024 | -$39.56M | – |
| FY2023 | Dec 31, 2023 | -$38.43M | – |
| FY2022 | Dec 31, 2022 | -$54.34M | – |
| FY2021 | Dec 31, 2021 | -$37.62M | – |
| FY2020 | Dec 31, 2020 | -$25.74M | – |
| FY2019 | Dec 31, 2019 | -$26.21M | – |
| FY2018 | Dec 31, 2018 | -$30.07M | – |
| FY2017 | Dec 31, 2017 | -$48.36M | – |
| FY2016 | Dec 31, 2016 | -$35.81M | – |
| FY2015 | Dec 31, 2015 | -$29.89M | – |
| FY2014 | Dec 31, 2014 | -$16.81M | – |
| FY2013 | Dec 31, 2013 | -$9.54M | – |
| FY2012 | Dec 31, 2012 | -$15.19M | – |
| FY2011 | Dec 31, 2011 | -$4.56M | – |
| FY2010 | Dec 31, 2010 | -$1.63M | – |
| FY2009 | Dec 31, 2009 | -$7.59M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.65M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.00M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.37M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.57M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.01M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.25M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.26M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.94M | – |
| Q2 FY2024 | Jun 30, 2024 | -$11.14M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.23M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.19M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.18M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.87M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.20M | – |
| Q4 FY2022 | Dec 31, 2022 | -$12.27M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.12M | – |
| Q2 FY2022 | Jun 30, 2022 | -$12.13M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.82M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.17M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.61M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.66M | – |
| Q1 FY2021 | Mar 31, 2021 | -$13.18M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.72M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.88M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.13M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.02M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.60M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.70M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.67M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.23M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.94M | – |
| Q3 FY2018 | Sep 30, 2018 | -$8.22M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.94M | – |
| Q1 FY2018 | Mar 31, 2018 | -$9.96M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.51M | – |
| Q3 FY2017 | Sep 30, 2017 | -$16.48M | – |
| Q2 FY2017 | Jun 30, 2017 | -$9.22M | – |
| Q1 FY2017 | Mar 31, 2017 | -$15.15M | – |
| Q4 FY2016 | Dec 31, 2016 | -$9.39M | – |
| Q3 FY2016 | Sep 30, 2016 | -$7.58M | – |
See a number that looks wrong?